Inhibitors of HCVNS5B polymerase: Synthesis and structureactivity relationships of unsymmetrical 1-hydroxy-4,4-dialkyl-3-oxo-3,4-dihydronaphthalene benzothiadiazine derivatives

被引:29
作者
Krueger, A. Chris [1 ]
Madigan, Darold L. [1 ]
Green, Brian E. [1 ]
Hutchinson, Douglas K. [1 ]
Jiang, Wen W. [1 ]
Kati, Warren M. [1 ]
Liu, Yaya [1 ]
Maring, Clarence J. [1 ]
Masse, Sherie V. [1 ]
McDaniel, Keith F. [1 ]
Middleton, Tim R. [1 ]
Mo, Hongmei [1 ]
Molla, Akhteruzzaman [1 ]
Montgomery, Debra A. [1 ]
Ng, Teresa I. [1 ]
Kempf, Dale J. [1 ]
机构
[1] Abbott Labs, Infect Dis Res, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA
关键词
HCV; NS5B; polymerase; 1-hydroxy-4,4-dialkyl-3-oxo 3,4-dihydronaphthalene benzothiadiazine;
D O I
10.1016/j.bmcl.2007.01.072
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Substituted 1-hydroxy-4,4-dialkyl-3-oxo-3,4-dihydronaphthalene benzothiadiazine derivatives were investigated as inhibitors of genotype 1 HCV polymerase. Structure-activity relationship patterns for this class of compounds are discussed. It was found that the saturated alkane dialkyl units provided the most active analogs. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2289 / 2292
页数:4
相关论文
共 21 条
[1]   The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].
Alter, MJ ;
Kruszon-Moran, D ;
Nainan, OV ;
McQuillan, GM ;
Gao, FX ;
Moyer, LA ;
Kaslow, RA ;
Margolis, HS .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :556-562
[2]  
[Anonymous], 1997, HEPATOLOGY, V26, pS2
[3]   Efficient initiation of HCV RNA replication in cell culture [J].
Blight, KJ ;
Kolykhalov, AA ;
Rice, CM .
SCIENCE, 2000, 290 (5498) :1972-1974
[4]  
BOSSE TD, UNPUB
[5]   ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME [J].
CHOO, QL ;
KUO, G ;
WEINER, AJ ;
OVERBY, LR ;
BRADLEY, DW ;
HOUGHTON, M .
SCIENCE, 1989, 244 (4902) :359-362
[6]   A highly efficient, asymmetric synthesis of benzothiadiazine-substituted tetramic acids: Potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase [J].
Fitch, DM ;
Evans, KA ;
Chai, DP ;
Duffy, KJ .
ORGANIC LETTERS, 2005, 7 (24) :5521-5524
[7]   Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. [J].
Fried, MW ;
Shiffman, ML ;
Reddy, KR ;
Smith, C ;
Marinos, G ;
Goncales, FL ;
Haussinger, D ;
Diago, M ;
Carosi, G ;
Dhumeaux, D ;
Craxi, A ;
Lin, A ;
Hoffman, J ;
Yu, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :975-982
[8]   Derivatives of 2,5-diaminobenzenesulfonamide [J].
Goldfarb, AR ;
Berk, B .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1943, 65 :738-739
[9]   Control of hepatitis C: A medicinal chemistry perspective [J].
Gordon, CP ;
Keller, PA .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (01) :1-20
[10]  
Hutchinson KD, 2005, PCT Int Appl, Patent No. [WO2005019191, 2005019191]